Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Neuroscience Letters
|
August 4, 1995
Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response
J W Dailey, J H Cheong, K H Ko, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1991
Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection
J F Wheeler, L E Adams, A B Mongey, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1989
Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus
L E Adams, C E Sanders, R A Budinsky, et al.
Lupus
|
April 1, 1993
Genetic, immunologic and biotransformation studies of patients on procainamide
L E Adams, K Balakrishnan, S M Roberts, et al.
International Journal of Immunopharmacology
|
January 1, 1989
Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobin
S M Roberts, L E Adams, R Donovan-Brand, et al.
Brain Research Bulletin
|
January 1, 1994
Noradrenergic abnormalities in the genetically epilepsy-prone rat
P C Jobe, P K Mishra, R A Browning, et al.
Italian Journal of Neurological Sciences
|
February 1, 1995
The genetically epilepsy-prone rat (GEPR)
P C Jobe, P K Mishra, L E Adams-Curtis, et al.
International Journal of Immunopharmacology
|
January 1, 1990
Effects of procainamide hydroxylamine on generation of reactive oxygen species by macrophages and production of cytokines
L E Adams, S M Roberts, J M Carter, et al.
Life Sciences
|
January 1, 1996
Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)
J W Dailey, Q S Yan, L E Adams-Curtis, et al.
The Physiologist
|
June 1, 1994
The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation
P C Jobe, L E Adams-Curtis, T F Burks, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Neuroscience Letters
|
August 4, 1995
Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response
J W Dailey, J H Cheong, K H Ko, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1991
Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection
J F Wheeler, L E Adams, A B Mongey, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1989
Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus
L E Adams, C E Sanders, R A Budinsky, et al.
Lupus
|
April 1, 1993
Genetic, immunologic and biotransformation studies of patients on procainamide
L E Adams, K Balakrishnan, S M Roberts, et al.
International Journal of Immunopharmacology
|
January 1, 1989
Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobin
S M Roberts, L E Adams, R Donovan-Brand, et al.
Brain Research Bulletin
|
January 1, 1994
Noradrenergic abnormalities in the genetically epilepsy-prone rat
P C Jobe, P K Mishra, R A Browning, et al.
Italian Journal of Neurological Sciences
|
February 1, 1995
The genetically epilepsy-prone rat (GEPR)
P C Jobe, P K Mishra, L E Adams-Curtis, et al.
International Journal of Immunopharmacology
|
January 1, 1990
Effects of procainamide hydroxylamine on generation of reactive oxygen species by macrophages and production of cytokines
L E Adams, S M Roberts, J M Carter, et al.
Life Sciences
|
January 1, 1996
Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)
J W Dailey, Q S Yan, L E Adams-Curtis, et al.
The Physiologist
|
June 1, 1994
The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation
P C Jobe, L E Adams-Curtis, T F Burks, et al.
Page
of 6